Preparation of Indigo Naturalis and High Performance Liquid Chromatography (HPLC) Analysis

ZS Zhongmei Sun
JL Junxiang Li
YD Yi Dai
WW Wenting Wang
RS Rui Shi
ZW Zhibin Wang
PD Panghua Ding
QL Qiongqiong Lu
HJ Hui Jiang
WP Wenjing Pei
XZ Xingjie Zhao
YG Yi Guo
JL Jiali Liu
XT Xiang Tan
TM Tangyou Mao
request Request a Protocol
ask Ask a question
Favorite

Indigo naturalis concentrated granules were purchased from the Pharmacy Department of Dongfang Hospital, Beijing University of Chinese Medicine (Beijing, China). The herb was extracted using a method of stimulated family decoction, then the extracts were concentrated, dried to form granules. This process was performed by Beijing Tcmages Pharmaceutical Co., Ltd. (Beijing, China) according to Good Manufacturing Practice (GMP) for Drugs (Chinese FDA) to guarantee the quality control. HPLC was carried out to identify the main chemical constituents. The reference standards of indigo and indirubin were purchased from National Institutes for Food and Drug Control (Beijing, China). Then, these two major components of indigo naturalis were analyzed by Agilent 1260 series HPLC system (Agilent Technologies, Palo Alto, CA, United States). The chromatographic separation was performed with Kromasil 100-5-C18 (250 mm × 4.6 mm, 5 μm) column (Nouryon, Bohus, Sweden) under isocratic flow of 55%–80% acetonitrile in 0–15 min at 25°C (1.0 mL/min). The injection volume was 10 μl and the wavelength of the detector was set at 286 nm.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A